DJIA 16,816.10 39.67 0.24%
NASDAQ 4,742.66 -38.61 -0.81%
S&P 500 1,981.29 -5.76 -0.29%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel

Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February

Ariad Pharmaceuticals' shares rocket to their highest levels since last Spring following a double-dose of positive news for shareholders. Find out whether this momentum can continue.

Interesting ARIA Call Options For April 10th

What Sarissa Capital's Proxy Fight Means For Ariad Investors

JMP Feeling Mostly Good On 4 Drug, Healthcare Stocks

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More

Friday's ETF with Unusual Volume: PTH

Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today

Ariad Pharmaceuticals shares are jumping following its earnings yesterday and news of an upcoming proxy fight.

Technical Breakout In Ariad Pharmaceuticals

Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger